These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36138191)

  • 1. Association Between Gut Hormones and Weight Change After Bariatric Arterial Embolization: Results from the BEAT Obesity Trial.
    Latif MA; Tunacao JM; Fu Y; Moran TH; Yenokyan G; Fischman AM; Cheskin LJ; Holly BP; Hong K; Shin EJ; Steele KE; Kraitchman DL; Arepally A; Weiss CR
    Cardiovasc Intervent Radiol; 2023 Feb; 46(2):220-228. PubMed ID: 36138191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bariatric Arterial Embolization with Non-spherical Polyvinyl Alcohol Particles for Ghrelin Suppression in a Swine Model.
    Kim JM; Kim MD; Han K; Muqmiroh L; Kim SU; Kim GM; Kwon J; Park SI; Won JY; Lee DY
    Cardiovasc Intervent Radiol; 2017 May; 40(5):744-749. PubMed ID: 28184958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Safety of Bariatric Arterial Embolization: Preliminary Results of the BEAT Obesity Trial.
    Weiss CR; Akinwande O; Paudel K; Cheskin LJ; Holly B; Hong K; Fischman AM; Patel RS; Shin EJ; Steele KE; Moran TH; Kaiser K; Park A; Shade DM; Kraitchman DL; Arepally A
    Radiology; 2017 May; 283(2):598-608. PubMed ID: 28195823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans.
    Yousseif A; Emmanuel J; Karra E; Millet Q; Elkalaawy M; Jenkinson AD; Hashemi M; Adamo M; Finer N; Fiennes AG; Withers DJ; Batterham RL
    Obes Surg; 2014 Feb; 24(2):241-52. PubMed ID: 23996294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bariatric Embolization in the Treatment of Patients with a Body Mass Index Between 30 and 39.9 kg/m
    Levigard RB; Serrão H; Castro C; Matos P; Mattos F; Madeira E; Rosseti CL; de Carvalho DP; Dantas JR; Zajdenverg L; Madeira M
    Cardiovasc Intervent Radiol; 2021 Apr; 44(4):598-606. PubMed ID: 33527186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass: a randomized clinical trial.
    Chronaiou A; Tsoli M; Kehagias I; Leotsinidis M; Kalfarentzos F; Alexandrides TK
    Obes Surg; 2012 Nov; 22(11):1761-70. PubMed ID: 22911148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bariatric Arterial Embolization: Effect of Microsphere Size on the Suppression of Fundal Ghrelin Expression and Weight Change in a Swine Model.
    Fu Y; Weiss CR; Paudel K; Shin EJ; Kedziorek D; Arepally A; Anders RA; Kraitchman DL
    Radiology; 2018 Oct; 289(1):83-89. PubMed ID: 29989526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY.
    Chandarana K; Gelegen C; Karra E; Choudhury AI; Drew ME; Fauveau V; Viollet B; Andreelli F; Withers DJ; Batterham RL
    Diabetes; 2011 Mar; 60(3):810-8. PubMed ID: 21292870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balancing Safety and Efficacy to Determine the Most Suitable Size of Imaging-Visible Embolic Microspheres for Bariatric Arterial Embolization in a Preclinical Model.
    Fu Y; Abiola G; Tunacao J; Vairavamurthy JP; Nwoke F; Dreher M; Shin EJ; Anders RA; Kraitchman DL; Weiss CR
    J Vasc Interv Radiol; 2023 Dec; 34(12):2224-2232.e3. PubMed ID: 37684003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic greater curvature plication in morbidly obese women with type 2 diabetes: effects on glucose homeostasis, postprandial triglyceridemia and selected gut hormones.
    Bradnova O; Kyrou I; Hainer V; Vcelak J; Halkova T; Sramkova P; Dolezalova K; Fried M; McTernan P; Kumar S; Hill M; Kunesova M; Bendlova B; Vrbikova J
    Obes Surg; 2014 May; 24(5):718-26. PubMed ID: 24307436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight Regain After Gastric Bypass: Influence of Gut Hormones.
    Santo MA; Riccioppo D; Pajecki D; Kawamoto F; de Cleva R; Antonangelo L; Marçal L; Cecconello I
    Obes Surg; 2016 May; 26(5):919-25. PubMed ID: 26450709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.
    Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Jacobsen SH; Clausen TR; Worm D; Hartmann B; Rehfeld JF; Damgaard M; Madsen JL; Madsbad S; Holst JJ; Hansen DL
    Int J Obes (Lond); 2013 Nov; 37(11):1452-9. PubMed ID: 23419600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bariatric Arterial Embolization with Calibrated Radiopaque Microspheres and an Antireflux Catheter Suppresses Weight Gain and Appetite-Stimulating Hormones in Swine.
    Weiss CR; Fu Y; Beh C; Hu C; Kedziorek D; Shin EJ; Anders RA; Arepally A; Kraitchman DL
    J Vasc Interv Radiol; 2020 Sep; 31(9):1483-1491. PubMed ID: 32800664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Fasting and Prandial Gut and Adiposity Hormones Following Vertical Sleeve Gastrectomy or Roux-en-Y-Gastric Bypass: an 18-Month Prospective Study.
    Alamuddin N; Vetter ML; Ahima RS; Hesson L; Ritter S; Minnick A; Faulconbridge LF; Allison KC; Sarwer DB; Chittams J; Williams NN; Hayes MR; Loughead JW; Gur R; Wadden TA
    Obes Surg; 2017 Jun; 27(6):1563-1572. PubMed ID: 28004304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-month changes in ghrelin and glucagon-like peptide-1 with weight loss are unrelated to long-term weight regain in obese older adults.
    Rejeski JJ; Fanning J; Nicklas BJ; Rejeski WJ
    Int J Obes (Lond); 2021 Apr; 45(4):888-894. PubMed ID: 33526855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3-36.
    Iepsen EW; Lundgren J; Holst JJ; Madsbad S; Torekov SS
    Eur J Endocrinol; 2016 Jun; 174(6):775-84. PubMed ID: 26976129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Sleeve Gastrectomy on Ghrelin, GLP-1, PYY, and GIP Gut Hormones: A Systematic Review and Meta-analysis.
    McCarty TR; Jirapinyo P; Thompson CC
    Ann Surg; 2020 Jul; 272(1):72-80. PubMed ID: 31592891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting Ghrelin and Postprandial GLP-1 Levels in Patients With Morbid Obesity and Medical Comorbidities After Sleeve Gastrectomy and One-anastomosis Gastric Bypass: A Randomized Clinical Trial.
    Roushdy A; Abdel-Razik MA; Emile SH; Farid M; Elbanna HG; Khafagy W; Elshobaky A
    Surg Laparosc Endosc Percutan Tech; 2020 Aug; 31(1):28-35. PubMed ID: 32810030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subject standardization, acclimatization, and sample processing affect gut hormone levels and appetite in humans.
    Chandarana K; Drew ME; Emmanuel J; Karra E; Gelegen C; Chan P; Cron NJ; Batterham RL
    Gastroenterology; 2009 Jun; 136(7):2115-26. PubMed ID: 19233179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.